Company Profiles

driven by the PitchBook Platform

Orphazyme

Description

Operator of a biotech company created to develop treatments for protein misfolding diseases, including lysosomal storage diseases with neurological pathologies, and neuro-degenerative disorders. The company's biotech facilities develops therapeutics for the treatment of lysosomal storage diseases, a group of rare genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, enabling patients to survive premature death.

2009

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$15M

Latest Deal Amount

$66M

Total Amount Raised

Description

Operator of a biotech company created to develop treatments for protein misfolding diseases, including lysosomal storage diseases with neurological pathologies, and neuro-degenerative disorders. The company's biotech facilities develops therapeutics for the treatment of lysosomal storage diseases, a group of rare genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, enabling patients to survive premature death.

Website:

www.orphazyme.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Therapeutic Devices

Primary Office

Ole Maaløes Vej 3 2200 CopenhagenDenmark +45 7070 2980
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Orphazyme's full profile, request a free trial.

Orphazyme Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Orphazyme Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aescap VentureVenture CapitalMinority000 0000000 0000
ALS Investment FundVenture CapitalMinority000 0000000 0000
IdInvest PartnersPE/BuyoutMinority000 0000000 0000
Kurma PartnersVenture CapitalMinority000 0000000 0000
Life Sciences PartnersVenture CapitalMinority000 0000000 0000
Aescap Venture Venture Capital
ALS Investment Fund Venture Capital
IdInvest Partners PE/Buyout
Kurma Partners Venture Capital
Life Sciences Partners Venture Capital

Orphazyme Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Anders Mørkeberg Hinsby Ph.DCo-Founder & Chief Executive Officer
Anders VadsholtChief Financial Officer
Thomas Kirkegaard Jensen Ph.DCo-Founder & Chief Scientific Officer
Soren Neve Ph.DDirector of pharmacology
Martin KornumCo-Founder, Director of IPR and Board Member
Anders Mørkeberg Hinsby Ph.D Co-Founder & Chief Executive Officer
Anders Vadsholt Chief Financial Officer
Thomas Kirkegaard Jensen Ph.D Co-Founder & Chief Scientific Officer
Soren Neve Ph.D Director of pharmacology
Martin Kornum Co-Founder, Director of IPR and Board Member

Orphazyme Board Members (11)

NameRepresentingRoleSinceContact
Info
Bo Jesper Hansen Ph.DSelfBoard Member000 0000
Georges Gemayel Ph.DSelfChairman000 0000
Kim Dueholm Ph.DNovoPartner000 0000
Martijn KleijwegtLife Sciences PartnersFounder, Co-Owner & Managing Partner000 0000
Martin Bonde Ph.DSelfBoard Member000 0000
Bo Jesper Hansen Ph.D Board Member Self
Georges Gemayel Ph.D Chairman Self
Kim Dueholm Ph.D Partner Novo
Martijn Kleijwegt Founder, Co-Owner & Managing Partner Life Sciences Partners
Martin Bonde Ph.D Board Member Self
Request full access to PitchBook